Effect of WRAD Lens on Axial Growth and Refraction in Low-hyperopic Chinese Children
1 other identifier
interventional
117
0 countries
N/A
Brief Summary
Myopia is one of the most common visual impairments worldwide.This not only poses long-term risks to individual health but also imposes significant medical and economic burdens on society. \[6\] Therefore, delaying the onset of myopia and effectively controlling its progression has become an urgent issue that needs to be addressed.In recent years, a new type of highly aspherical lenslet (HAL) has been proposed. Its optical design includes a refractive correction area in the central region and a peripheral annular area. This annular area can form a "myopic defocus zone", increasing the myopic defocus signal around the retina. Studies have confirmed that this design can effectively slow down the progression of myopia in already myopic children. However, it is currently unclear whether this lens has a preventive effect on children who are not yet myopic but have a risk of developing myopia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2026
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 26, 2026
CompletedStudy Start
First participant enrolled
July 1, 2026
CompletedFirst Posted
Study publicly available on registry
July 6, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2030
July 6, 2026
June 1, 2026
3.4 years
June 26, 2026
June 26, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Changes in the axial length
The changes in axial length of the eyes in the experimental group and the control group in the first and second years
baseline, 6-month, 12-month, 18-month, 24-month
Change in the spherical equivalent
The changes in spherical equivalent in the experimental group and the control group in the first and second years
Baseline, 6-month, 12-month, 18-month, 24-month
Secondary Outcomes (2)
Changes in axial length
Baseline, 6-month, 12-month, 18-month, 24-month
Change in equivalent spherical
Baseline, 6-month, 12-month, 18-month, 24-month
Study Arms (3)
Group A
EXPERIMENTALParticipants will be wearing with-the-rule astigmatic defocus lens glasses. The lens was prescribed with 0.00 diopters. It is recommended to wear it for ≥ 10 hours per day
Group B
EXPERIMENTALParticipants will be wearing with-the-rule astigmatic defocus lens glasses (non-plano defocus spectacles); the central optical zone degree completely correct their baseline under cycloplegia refractive errors. It is recommended to wear it for ≥ 10 hours per day
Group C (control group)
PLACEBO COMPARATORParticipants will be wearing traditional single vision lens, lens has no correction function. It is recommended to wear it for ≥ 10 hours per day
Interventions
The magnitude of the central optical zone completely corrected their refractive errors under baseline cycloplegia
Eligibility Criteria
You may qualify if:
- Children aged 6 to 9 with low hyperopia, regardless of gender
- The refractive error is between 0 and 2.00D
- The best corrected visual acuity of both eyes is ≥ 0.10 LogMAR
- The subjects themselves and their guardians voluntarily participated
You may not qualify if:
- Systemic diseases or eye diseases
- Received myopia control treatment through medication or optical
- Any situation where participation is deemed unsuitable by the investigator
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- He Eye Hospitallead
- He Eye Specialist Hospitalcollaborator
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 26, 2026
First Posted
July 6, 2026
Study Start
July 1, 2026
Primary Completion (Estimated)
December 1, 2029
Study Completion (Estimated)
July 1, 2030
Last Updated
July 6, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share